Ciprofloxacin Lactate Soluble structure
|
Common Name | Ciprofloxacin Lactate Soluble | ||
|---|---|---|---|---|
| CAS Number | 97867-33-9 | Molecular Weight | 403.404 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 656.4±55.0 °C at 760 mmHg | |
| Molecular Formula | C20H24FN3O6 | Melting Point | 255-257ºC | |
| MSDS | N/A | Flash Point | 350.8±31.5 °C | |
Use of Ciprofloxacin Lactate SolubleCiprofloxacin (Bay-09867) lactate is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin lactate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin lactate has anti-proliferative activity and induces apoptosis. Ciprofloxacin lactate is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4]. |
| Name | 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,2-hydroxypropanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Ciprofloxacin (Bay-09867) lactate is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin lactate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin lactate has anti-proliferative activity and induces apoptosis. Ciprofloxacin lactate is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4]. |
|---|---|
| Related Catalog | |
| In Vitro | Ciprofloxacin (Bay-09867) lactate (5-50 μg/mL; 0-24 h; tendon cells) inhibits cell proliferation and causes cell cycle arrest at the G2/M phase[1]. Ciprofloxacin (Bay-09867) lactate shows potent activity against Y. pestis and B. anthracis with MIC90 of 0.03 μg/mL and 0.12 μg/mL, respectively[2]. Cell Cycle Analysis[1] Cell Line: Tendon cells Concentration: 5, 10, 20 and 50 μg/mL Incubation Time: 24 hours Result: Decreased the cellularity of tendon cells. Apoptosis Analysis[1] Cell Line: Tendon cells Concentration: 50 μg/mL Incubation Time: 24 hours Result: Arrested cell cycle at the G2/M phase and inhibited cell division in tendon cells. Western Blot Analysis[1] Cell Line: Tendon cells Concentration: 50 μg/mL Incubation Time: 0, 6, 12, 17 and 24 hours Result: Down-regulated the expression of CDK-1 and cyclin B protein and mRNA. Up-regulated the expression of PLK-1 protein. |
| In Vivo | Ciprofloxacin (Bay-09867) lactate (30 mg/kg; i.p.; for 24 hours; BALB/c mice) has protection against Y. pestis in murine model of pneumonic plague[3]. Ciprofloxacin (Bay-09867) lactate (100 mg/kg; i.g.; daily, for 4 weeks; C57BL/6J mice) accelerates aortic root enlargement and increases the incidence of aortic dissection and rupture by decreases LOX level and increases MMP levels and activity in the aortic wall[4]. Ciprofloxacin (Bay-09867) lactate (100 mg/kg; i.g.; daily, for 4 weeks; C57BL/6J mice) induces DNA damage and release of DNA to the cytosol, mitochondrial dysfunction, and activation of cytosolic DNA sensor signaling. Ciprofloxacin lactate increases apoptosis and necroptosis in the aortic wall[4]. Animal Model: BALB/c mice[3] Dosage: 30 mg/kg Administration: Intraperitoneal injection; for 24 hours Result: Reduced the lung bacterial load in murine model of pneumonic plague. Animal Model: C57BL/6J mice[4] Dosage: 100 mg/kg Administration: Oral gavage; daily, for 4 weeks Result: Had aortic destruction that was accompanied by decreased LOX expression and increased MMP expression and activity. Animal Model: C57BL/6J mice[4] Dosage: 100 mg/kg Administration: Oral gavage; daily, for 4 weeks Result: Caused mitochondrial DNA and nuclear DNA damage, leading to mitochondrial dysfunction and ROS production. Increased apoptosis and necroptosis in the aortic wall. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 656.4±55.0 °C at 760 mmHg |
| Melting Point | 255-257ºC |
| Molecular Formula | C20H24FN3O6 |
| Molecular Weight | 403.404 |
| Flash Point | 350.8±31.5 °C |
| Exact Mass | 403.154358 |
| PSA | 100.87000 |
| LogP | 0.04 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.624 |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933491000 |
| HS Code | 2933491000 |
|---|---|
| Summary | 2933491000. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Flunase [inj.] |
| Cipobacter |
| Ciproflox [inj.] |
| Ciprobid Eye Drops |
| Ciproxin [inj.] |
| Flociprin [inj.] |
| Ciproxina [inj.] |
| Quintor Eye Drops |
| Ificipro |
| 1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic 2-hydroxypropanoic anhydride |
| MFCD01759747 |